These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29496754)

  • 21. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
    [No Abstract]   [Full Text] [Related]  

  • 22. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
    Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM
    Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis: are we making it incurable?
    Caminero JA; Matteelli A; Loddenkemper R
    Eur Respir J; 2013 Jul; 42(1):5-8. PubMed ID: 23813308
    [No Abstract]   [Full Text] [Related]  

  • 24. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
    Alame-Emane AK; Xu P; Pierre-Audigier C; Cadet-Daniel V; Shen X; Sraouia M; Siawaya JF; Takiff H; Gao Q; Gicquel B
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):679-84. PubMed ID: 25946359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical considerations to implement the shorter regimen to MDR-TB patients in China.
    Liu Q; Sun F; Li Y; Bao J; Zhang Y; Zhang W
    Clin Microbiol Infect; 2018 Oct; 24(10):1035-1036. PubMed ID: 29730223
    [No Abstract]   [Full Text] [Related]  

  • 27. Belarus and drug-resistant tuberculosis.
    Bull World Health Organ; 2019 Dec; 97(12):795-796. PubMed ID: 31819286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization.
    Viney K; Linh NN; Gegia M; Zignol M; Glaziou P; Ismail N; Kasaeva T; Mirzayev F
    Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33833074
    [No Abstract]   [Full Text] [Related]  

  • 29. Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Myanmar.
    Aung WW; Ei PW; Nyunt WW; Htwe MM; Win SM; Aye KT; Mon AS; Aung ST; Chang CL; Lee JS
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263056
    [No Abstract]   [Full Text] [Related]  

  • 30. [New tuberculosis drugs in resistant and multiresistant tuberculosis].
    Ramírez Lapausa M; Pascual Pareja JF; Noguerado Asensio A
    Med Clin (Barc); 2013 Oct; 141(7):306-13. PubMed ID: 23540388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensively drug-resistant tuberculosis, China.
    Tang S; Zhang Q; Yu J; Liu Y; Sha W; Sun H; Fan L; Gu J; Hao X; Yao L; Xiao H
    Emerg Infect Dis; 2011 Mar; 17(3):558-60. PubMed ID: 21392462
    [No Abstract]   [Full Text] [Related]  

  • 32. Antituberculosis Drug Resistance in Pulmonary Isolates of Mycobacterium tuberculosis, Cuba 2012-2014.
    Lemus D; Echemendía M; Díaz R; Llanes MJ; Suárez L; Marrero A
    MEDICC Rev; 2017 Jan; 19(1):10-15. PubMed ID: 28225540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trials to optimize treatment of multidrug-resistant tuberculosis.
    Mitnick CD; Castro KG; Harrington M; Sacks LV; Burman W
    PLoS Med; 2007 Nov; 4(11):e292. PubMed ID: 17988168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease].
    Baylan O
    Mikrobiyol Bul; 2011 Jan; 45(1):181-95. PubMed ID: 21341173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems.
    Villa S; Tagliani E; Borroni E; Castellotti PF; Ferrarese M; Ghodousi A; Lamberti A; Senatore S; Faccini M; Cirillo DM; Codecasa LR
    Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 34049944
    [No Abstract]   [Full Text] [Related]  

  • 36. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unsexy tuberculosis.
    Reichman LB
    Lancet; 2009 Jan; 373(9657):28. PubMed ID: 19121719
    [No Abstract]   [Full Text] [Related]  

  • 38. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of multidrug resistant tuberculosis.
    Daley CL; Caminero JA
    Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.